Cyclacel Pharmaceuticals Company Profile (NASDAQ:CYCC)

About Cyclacel Pharmaceuticals

Cyclacel Pharmaceuticals logoCyclacel Pharmaceuticals, Inc. operates in the field of cell cycle biology. The Company has generated various families of anticancer drugs that act on the cell cycle, including nucleoside analogs, cyclin dependent kinase (CDK) inhibitors, polo-like kinase (PLK) inhibitors and Aurora Kinase/vascular endothelial growth factor receptor (AK/VEGFR) inhibitors. Its family of anticancer drugs that act on the cell cycle include sapacitabine, seliciclib and CYC065. Its lead candidate, sapacitabine, is an orally available nucleoside analog. A number of nucleoside drugs, such as gemcitabine and cytarabine, also known as Ara-C, both generic drugs, are in use as conventional chemotherapies. Seliciclib, its lead CDK inhibitor, is an oral inhibitor of CDK2/9 enzymes that are central to the process of cell division and cell cycle control. Its second-generation CDK inhibitor, CYC065, is an inhibitor of CDKs targeting CDK2/9 enzymes with utility in both hematological malignancies and solid tumors.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CYCC
  • CUSIP:
Key Metrics:
  • Previous Close: $7.05
  • 50 Day Moving Average: $5.41
  • 200 Day Moving Average: $5.00
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.29
  • P/E Growth: 0.00
  • Market Cap: $21.98M
  • Outstanding Shares: 3,118,000
  • Beta: 3.55
Additional Links:
Companies Related to Cyclacel Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Cyclacel Pharmaceuticals (NASDAQ:CYCC) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $60.00 (751.06% upside)

Analysts' Ratings History for Cyclacel Pharmaceuticals (NASDAQ:CYCC)
Show:
DateFirmActionRatingPrice TargetDetails
8/12/2016HC WainwrightReiterated RatingBuyView Rating Details
12/17/2014JMP SecuritiesDowngradeOutperform -> Market Perform$108.00View Rating Details
(Data available from 8/25/2014 forward)

Earnings

Earnings History for Cyclacel Pharmaceuticals (NASDAQ:CYCC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/10/2016        
8/10/2016Q216($1.01)ViewListenView Earnings Details
5/11/2016Q116($0.09)$512.00 million$139.00 millionViewListenView Earnings Details
3/24/2016Q4($0.08)($0.10)ViewListenView Earnings Details
11/12/2015Q315($0.09)($0.08)ViewListenView Earnings Details
8/11/2015Q215($0.10)ViewListenView Earnings Details
5/12/2015Q115($0.25)($0.19)ViewListenView Earnings Details
3/24/2015Q414($0.26)($0.20)ViewN/AView Earnings Details
11/11/2014Q314($0.26)($0.22)ViewN/AView Earnings Details
8/12/2014Q214($0.30)($0.22)ViewN/AView Earnings Details
5/13/2014Q114($0.26)($0.25)ViewN/AView Earnings Details
3/25/2014Q413($0.33)($0.19)$0.09 million$0.30 millionViewN/AView Earnings Details
11/12/2013Q3($0.31)($0.31)ViewListenView Earnings Details
8/14/2013Q2 2013($0.10)$0.03 million$0.26 millionViewN/AView Earnings Details
5/13/2013Q1 2013($1.18)ViewN/AView Earnings Details
11/12/2012Q312($0.37)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Cyclacel Pharmaceuticals (NASDAQ:CYCC)
Current Year EPS Consensus Estimate: $-3.89 EPS
Next Year EPS Consensus Estimate: $-5.48 EPS

Dividends

Current Dividend Information for Cyclacel Pharmaceuticals (NASDAQ:CYCC)
Annual Dividend:$0.15
Dividend Yield:2.13%
Payout Ratio:-2.75% (Based on Trailing 12 Months of Earnings)
-3.86% (Based on Current Year Consensus EPS Estimate)
-2.74% (Based on Next Year Consensus EPS Estimate)

Dividend History for Cyclacel Pharmaceuticals (NASDAQ:CYCC)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/9/2016Annual$0.157/13/20167/17/20168/1/2016
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Cyclacel Pharmaceuticals (NASDAQ:CYCC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/20/2014Sam L BarkerDirectorBuy3,100$3.00$9,300.00View SEC Filing  
5/21/2013Lloyd SemsDirectorBuy33,333$3.00$99,999.00View SEC Filing  
5/21/2013Paul McbarronCFOBuy12,948$3.03$39,232.44View SEC Filing  
5/21/2013Spiro George RombotisInsiderBuy100,000$3.00$300,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Cyclacel Pharmaceuticals (NASDAQ:CYCC)
DateHeadline
News IconNotable Active Movers: Resolute Energy Corp (NYSE:REN), Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) - NYSE Journal (press release) (NASDAQ:CYCC)
stockznews.com - August 24 at 4:31 PM
insidermonkey.com logoMovers and Shakers In Biotech: Cyclacel Pharmaceuticals Inc (CYCC) and Corium International Inc (CORI) - Insider Monkey (blog) (NASDAQ:CYCC)
www.insidermonkey.com - August 24 at 4:31 PM
News IconInvestor's Alert: Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC), Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) - Newburg Press (NASDAQ:CYCC)
newburghpress.com - August 23 at 9:42 PM
seekingalpha.com logoCyclacel's Date With Decitabine - Seeking Alpha (NASDAQ:CYCC)
seekingalpha.com - August 23 at 4:39 PM
News IconAnother Volatile Session to Start the Week (NASDAQ:CYCC)
www.fxstreet.com - August 23 at 8:45 AM
marketexclusive.com logoMovers and Shakers In Biotech: Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) and Corium International Inc (NASDAQ:CORI) (NASDAQ:CYCC)
marketexclusive.com - August 22 at 4:37 PM
schaeffersresearch.com logoCyclacel Pharmaceuticals Inc (CYCC) Spikes On Tang Capital Stake (NASDAQ:CYCC)
www.schaeffersresearch.com - August 22 at 4:37 PM
thestreet.com logoHere's Why Cyclacel Pharmaceuticals (CYCC) Stock Is Surging Today (NASDAQ:CYCC)
www.thestreet.com - August 22 at 4:37 PM
thestreet.com logoCyclacel Stock Runs on Momentum Rocket Fueled by 'Dumb & Dumber' Optimism (NASDAQ:CYCC)
www.thestreet.com - August 22 at 4:37 PM
investorplace.com logoCyclacel Pharmaceuticals Inc (CYCC): Don’t Believe the Hype (NASDAQ:CYCC)
investorplace.com - August 22 at 12:58 PM
investornewswire.com logoWill Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Hit $60 Price Target? - Investor Newswire (NASDAQ:CYCC)
www.investornewswire.com - August 21 at 4:19 PM
News IconStock Sliding Lower in Trade: Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) - Post News (NASDAQ:CYCC)
www.kentuckypostnews.com - August 19 at 3:38 PM
capitalcube.com logoETF’s with exposure to Cyclacel Pharmaceuticals, Inc. : August 19, 2016 (NASDAQ:CYCC)
www.capitalcube.com - August 19 at 3:38 PM
News IconCyclacel Pharmaceuticals, Inc.'s (CYCC): Major Stock of Recent Trade - Hot Stocks Point (NASDAQ:CYCC)
www.hotstockspoint.com - August 19 at 9:34 AM
News IconShares Heading Higher in Session: Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) - Post News (NASDAQ:CYCC)
www.kentuckypostnews.com - August 17 at 9:53 PM
News IconChecklist Stock of the Tuesday - Cyclacel Pharmaceuticals, Inc.'s (CYCC) - Hot Stocks Point (NASDAQ:CYCC)
www.hotstockspoint.com - August 17 at 9:53 PM
biz.yahoo.com logoCYCLACEL PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:CYCC)
biz.yahoo.com - August 17 at 4:44 PM
News IconTurn-Down Day (NASDAQ:CYCC)
www.fxstreet.com - August 17 at 9:15 AM
News IconWhy Wall Street Is Bullish On Cyclacel Pharmaceuticals Inc. (NASDAQ: CYCC) - Scibility Media (NASDAQ:CYCC)
scibilitymedia.com - August 15 at 10:03 PM
seekingalpha.com logoCyclacel Pharmaceuticals, Inc.'s (CYCC) CEO Spiro Rombotis on Q2 2016 Results - Earnings Call Transcript (NASDAQ:CYCC)
seekingalpha.com - August 10 at 10:44 PM
ftsenews.co.uk logoCyclacel Pharmaceuticals, Inc. (CYCC) Updated Price Targets - FTSE News (NASDAQ:CYCC)
www.ftsenews.co.uk - August 7 at 9:00 AM
live-pr.com logoCyclacel Pharmaceuticals, Inc. (CYCC) - Financial and Strategic SWOT Analysis Review - New Report Available (NASDAQ:CYCC)
www.live-pr.com - August 4 at 4:44 PM
twst.com logoCyclacel Pharmaceuticals Inc.: Cyclacel Pharmaceuticals to Release Second Quarter 2016 Financial Results (NASDAQ:CYCC)
www.twst.com - August 3 at 4:39 PM
publicnow.com logoCyclacel Pharmaceuticals to Release Second Quarter 2016 Financial Results (NASDAQ:CYCC)
www.publicnow.com - August 3 at 9:20 AM
streetinsider.com logoCyclacel Pharma (CYCC) Says Preclinical Data Shows CYC065 Demonstrates Promising Activity in Uterine Serous ... - StreetInsider.com (NASDAQ:CYCC)
www.streetinsider.com - August 2 at 9:21 AM
investornewswire.com logoIs $60.024 Price Target Attainable For Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC)? - Investor Newswire (NASDAQ:CYCC)
www.investornewswire.com - July 23 at 4:27 PM
investornewswire.com logoStrong Sell Calls For Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) At 0 - Investor Newswire (NASDAQ:CYCC)
www.investornewswire.com - July 17 at 9:06 AM
News IconCyclacel Pharmaceuticals Inc (NASDAQ:CYCC) Shifting Institutional Investors Sentiment - Press Telegraph (NASDAQ:CYCC)
presstelegraph.com - July 14 at 4:44 PM
News IconCyclacel Pharmaceuticals Incorporated (NASDAQ:CYCC) Sellers Increased By 176.26% Their Shorts - Consumer Eagle (NASDAQ:CYCC)
www.consumereagle.com - July 14 at 7:16 AM
investornewswire.com logoIs $60.024 Within Reach For Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC)? - Investor Newswire (NASDAQ:CYCC)
www.investornewswire.com - July 11 at 9:20 AM
fiscalstandard.com logoBroker Outlook For Cyclacel Pharmaceuticals, Inc. (CYCC) - Fiscal Standard (NASDAQ:CYCC)
www.fiscalstandard.com - July 6 at 10:21 PM
biz.yahoo.com logoCYCLACEL PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:CYCC)
biz.yahoo.com - July 6 at 5:02 PM
investornewswire.com logoCyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Expected to Reach Highs Of $60.024 - Investor Newswire (NASDAQ:CYCC)
www.investornewswire.com - July 4 at 4:18 PM
fiscalstandard.com logoBroker Outlook For The Week Ahead Cyclacel Pharmaceuticals, Inc. (CYCC) - Fiscal Standard (NASDAQ:CYCC)
www.fiscalstandard.com - July 4 at 4:18 PM
fiscalstandard.com logoBrokers Issue Average Price Target Of 7.00 On Cyclacel Pharmaceuticals, Inc. (CYCC) - Fiscal Standard (NASDAQ:CYCC)
www.fiscalstandard.com - July 1 at 10:31 AM
News IconCyclacel Pharmaceuticals Incorporated (NASDAQ:CYCC) Shorted Shares Increased By 176.26% - Press Telegraph (NASDAQ:CYCC)
presstelegraph.com - June 30 at 10:04 AM
fiscalstandard.com logoCyclacel Pharmaceuticals, Inc. (CYCC) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:CYCC)
www.fiscalstandard.com - June 28 at 4:30 PM
investornewswire.com logoStrong Sell Calls Recommendations For Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) At 0 - Investor Newswire (NASDAQ:CYCC)
www.investornewswire.com - June 26 at 9:36 AM
streetinsider.com logoCyclacel Pharma (CYCC) Enters $4M At Market Issuance Sales Agreement (NASDAQ:CYCC)
www.streetinsider.com - June 24 at 11:16 AM
ftsenews.co.uk logoNew Broker Ratings For Cyclacel Pharmaceuticals, Inc. (CYCC) - FTSE News (NASDAQ:CYCC)
www.ftsenews.co.uk - June 23 at 9:30 PM
streetinsider.com logoCyclacel Pharma (CYCC) Enters $4M At Market Issuance Sales Agreement - StreetInsider.com (NASDAQ:CYCC)
www.streetinsider.com - June 23 at 9:30 PM
biz.yahoo.com logoCYCLACEL PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Mater (NASDAQ:CYCC)
biz.yahoo.com - June 23 at 4:39 PM
fiscalstandard.com logoCyclacel Pharmaceuticals, Inc. (CYCC) Current Analyst Ratings - Fiscal Standard (NASDAQ:CYCC)
www.fiscalstandard.com - June 22 at 4:42 PM
investornewswire.com logoStrong Buy Calls Count For Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) At 1 - Investor Newswire (NASDAQ:CYCC)
www.investornewswire.com - June 19 at 8:59 AM
kcregister.com logoEndocyte, Inc. (NASDAQ:ECYT) increased 1.10%: Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC), Freeport ... - KC Register (NASDAQ:CYCC)
www.kcregister.com - June 17 at 4:24 PM
streetinsider.com logoCyclacel Pharma (CYCC) Regains Nasdaq Listing Compliance - StreetInsider.com (NASDAQ:CYCC)
www.streetinsider.com - June 16 at 4:32 PM
streetupdates.com logoStocks inside Analysts Spotlight: Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) , Skyline Medical Inc. (NASDAQ ... - Street Updates (NASDAQ:CYCC)
www.streetupdates.com - June 8 at 11:29 AM
News IconAnalyst Overview: Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) - News Oracle (NASDAQ:CYCC)
www.newsoracle.com - June 7 at 4:36 PM
wallstrt24.com logoCyclacel Pharmaceuticals (NASDAQ:CYCC) & Kite Pharma Inc (NASDAQ:KITE) Healthcare Stocks on the Run - Wall Street 24 (NASDAQ:CYCC)
wallstrt24.com - June 7 at 4:36 PM
istreetwire.com logoActive Stocks in Pre-Market: Cyclacel Pharmaceuticals Inc(NASDAQ:CYCC), Amazon.com, Inc.(NASDAQ:AMZN) - iStreetWire (NASDAQ:CYCC)
istreetwire.com - June 7 at 12:22 PM

Social

Cyclacel Pharmaceuticals (NASDAQ:CYCC) Chart for Thursday, August, 25, 2016


Last Updated on 8/25/2016 by MarketBeat.com Staff